Clinical implications of tumor necrosis factor receptor 2 in breast cancer.

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Oncology Letters

• Publication date

  2017-08-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.3892/ol.2017.6410PMID 28789455PMCID PMC5530001
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Predictors of Altered Upper Extremity Function During the First Year After Breast Cancer Treatment

  2016cited by this paper
• GSE1 negative regulation by miR-489-5p promotes breast cancer cell proliferation and invasion.

  2016cited by this paper
• Identification of early breast cancer patient cohorts who may benefit from lapatinib therapy.

  2016cited by this paper
• Comparison of Clinicopathological Features and Prognosis in Triple-Negative and Non-Triple Negative Breast Cancer

  2016cited by this paper
• Estrogen-Receptor, Progesterone-Receptor and HER2 Status Determination in Invasive Breast Cancer. Concordance between Immuno-Histochemistry and MapQuant™ Microarray Based Assay

  2016cited by this paper
• The use of surgery in the treatment of ER+ early stage breast cancer in England: Variation by time, age and patient characteristics.

  2016cited by this paper
• Comparative analysis of the effects of radiotherapy versus radiotherapy after adjuvant chemotherapy on the composition of lymphocyte subpopulations in breast cancer patients.

  2016cited by this paper
• Chemotherapy in Premenopausal Breast Cancer Patients

  2015cited by this paper
• Progranulin promotes colorectal cancer proliferation and angiogenesis through TNFR2/Akt and ERK signaling pathways.

  2015cited by this paper
• Physician experiences and preferences in the treatment of HR+/HER2− metastatic breast cancer in the United States: a physician survey

  2015cited by this paper
• Physical activity, hormone replacement therapy and breast cancer risk: A meta-analysis of prospective studies.

  2015cited by this paper
• HER2 induced EMT and tumorigenicity in breast epithelial progenitor cells is inhibited by coexpression of EGFR

  2015cited by this paper
• The Modern Landscape of Endocrine Therapy for Premenopausal Women with Breast Cancer

  2015cited by this paper
• Clinical and Therapeutic Implications of Histone Acetylation in Breast Cancer.

  2015cited by this paper
• The variation and clinical significance of hormone receptors and Her-2 status from primary to metastatic lesions in breast cancer patients

  2015cited by this paper
• Association of TNF-α, TNFRSF1A and TNFRSF1B Gene Polymorphisms with the Risk of Sporadic Breast Cancer in Northeast Chinese Han Women

  2014cited by this paper
• The promotion of bone healing by progranulin, a downstream molecule of BMP-2, through interacting with TNF/TNFR signaling.

  2013cited by this paper
• Circulating Levels of TNF Receptor II Are Prognostic for Patients with Peripheral T-cell Non–Hodgkin Lymphoma

  2012cited by this paper
• Increased tumor necrosis factor receptor 1 expression in human colorectal adenomas.

  2012cited by this paper
• Prevention of LPS-Induced Acute Lung Injury in Mice by Progranulin

  2012cited by this paper
• Global cancer statistics

  2011cited by this paper
• The Growth Factor Progranulin Binds to TNF Receptors and Is Therapeutic Against Inflammatory Arthritis in Mice

  2011cited by this paper
• Role of tumor necrosis factor‐α and its receptors in human benign breast lesions and tumors (in situ and infiltrative)

  2006cited by this paper
• Tumor necrosis factor α promotes invasiveness of cholangiocarcinoma cells via its receptor, TNFR2

  2005cited by this paper
• A functional polymorphism of the tumor necrosis factor receptor-II gene associated with the survival and relapse prediction of breast carcinoma.

  2005cited by this paper
• Tumor necrosis factor alpha promotes invasiveness of cholangiocarcinoma cells via its receptor, TNFR2.

  2005cited by this paper
• Expression of both TNF-alpha receptor subtypes is essential for optimal skin tumour development.

  2004cited by this paper
• Transendothelial Migration of Myeloma Cells Is Increased by Tumor Necrosis Factor (TNF)-α via TNF Receptor 2 and Autocrine Up-Regulation of MCP-1

  2004cited by this paper
• Expression of both TNF-α receptor subtypes is essential for optimal skin tumour development

  2004cited by this paper
• [CEA, CA-19-9 and il-8, sTNFRII and sil-2R in persons at high risk of colorectal cancer].

  2003cited by this paper
• Role of tumor necrosis factor receptor 2 (TNFR2) in colonic epithelial hyperplasia and chronic intestinal inflammation in mice.

  2002cited by this paper
• Soluble TNF and IL-2 receptors in patients with breast cancer.

  2000cited by this paper
• Release of soluble IL-6 receptor (IL-6sR) in comparison with release of soluble TNF receptors (sTNF-Rs) by PMNs and WBC derived from breast cancer patients.

  1997cited by this paper

• Elucidating the Mechanism of Tetrastigma hemsleyanum in Attenuating Chronic Stress-Induced Elevation of Serum Tumor Markers Levels via Network Pharmacology and Molecular Docking

  2026cites this paper
• Targeting TNFR1-driven necroptosis in breast cancer

  2025cites this paper
• Multi-omics analysis reveals ultraviolet response insights for immunotherapy and prognosis

  2025cites this paper
• Cytokine Networks in Triple-Negative Breast Cancer: Mechanisms, Therapeutic Targets, and Emerging Strategies

  2025cites this paper
• The expression of tumor necrosis factor receptor 2 is correlated with the prognosis of cancer: a systematic review and meta-analysis

  2024cites this paper
• Understanding the role of TNFR2 signaling in the tumor microenvironment of breast cancer

  2024cites this paper
• Targeting TNFR2 for cancer immunotherapy: recent advances and future directions

  2024cites this paper
• Continuous TNF-α exposure in mammary epithelial cells promotes cancer phenotype acquisition via EGFR/TNFR2 activation

  2024cites this paper
• LINC00173 silence and estrone supply suppress ER+ breast cancer by estrogen receptor α degradation and LITAF activation

  2024cites this paper
• Aberrant frequency of TNFR2-expressing CD4+ FoxP3+ regulatory T cells in nasopharyngeal carcinoma patients.

  2023cites this paper
• TNFR2 deficiency impairs the growth of mouse colon cancer

  2023cites this paper
• The Roles of TNFR2 Signaling in Cancer Cells and the Tumor Microenvironment and the Potency of TNFR2 Targeted Therapy

  2022cites this paper
• Targeting TNFR2: A Novel Breakthrough in the Treatment of Cancer

  2022cites this paper
• Tumor Necrosis Factor Receptor 2 (TNFR2): An Emerging Target in Cancer Therapy

  2022cites this paper
• Anti-Tumor Necrosis Factor Receptor 2 Antibody Combined With Anti-PD-L1 Therapy Exerts Robust Antitumor Effects in Breast Cancer

  2021cites this paper
• The prognostic value of the C-reactive protein to albumin ratio in cancer

  2020cites this paper
• The dual role of tumor necrosis factor-alpha (TNF-α) in breast cancer: molecular insights and therapeutic approaches

  2020cites this paper
• Tumor microenvironmental plasmacytoid dendritic cells contribute to breast cancer lymph node metastasis via CXCR4/SDF-1 axis

  2019cites this paper
• Synergistic Effects of Nanomedicine Targeting TNFR2 and DNA Demethylation Inhibitor—An Opportunity for Cancer Treatment

  2019cites this paper
• A Perspective Review on the Role of Nanomedicine in the Modulation of TNF-TNFR2 Axis in Breast Cancer Immunotherapy

  2019cites this paper
• TNF Receptor 2 Makes Tumor Necrosis Factor a Friend of Tumors

  2018cites this paper
• Unleashing endogenous TNF-alpha as a cancer immunotherapeutic

  2018cites this paper
• High expression of tumor necrosis factor receptor 2 in tissue is associated with progression and prognosis of esophageal squamous cell carcinoma.

  2018cites this paper
• Association of IL-18 genetic polymorphisms and haplotypes with breast cancer risk in a Chinese population

  2017cites this paper